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Abstract
Background: Elastofibromas are benign soft tissue tumours mostly of the infrascapular region between
the thoracic wall, the serratus anterior and the latissimus dorsi muscle with a prevalence of up to 24% in
the elderly. The pathogenesis of the lesion is still unclear, but repetitive microtrauma by friction between
the scapula and the thoracic wall may cause the reactive hyperproliferation of fibroelastic tissue.
Methods: We present a series of seven cases with elastofibroma dorsi with reference to clinical findings,
further clinical course and functional results after resection, as well as recurrence. Data were obtained
retrospectively by clinical examination, phone calls to the patients' general practitioners and charts review.
Follow-up time ranged from four months to nine years and averaged 53 months.
Results: The patients presented with swelling of the infrascapular region or snapping scapula. In three
cases, the lesion was painful. The ratio men/women was 2/5 with a mean age of 64 years. The tumor sizes
ranged from 3 to 13 cm. The typical macroscopic aspect was characterized as poorly defined fibroelastic
soft tissue lesion with a white and yellow cut surface caused by intermingled remnants of fatty tissue.
Microscopically, the lesions consisted of broad collagenous strands and densely packed enlarged and
fragmented elastic fibres with mostly round shapes. In all patients but one, postoperative seroma (which
had to be punctuated) occurred after resection; however, at follow-up time, no patient reported any
decrease of function or sensation at the shoulder or the arm of the operated side. None of the patients
experienced a relapse.
Conclusion: In differential diagnosis of soft tissue tumors located at this specific site, elastofibroma should
be considered as likely diagnosis. Due to its benign behaviour, the tumor should be resected only in
symptomatic patients.
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Background
Elastofibromas are slowly growing benign tumors of soft
tissue origin. In 99% of the cases, they are located in the
inferior subscapular region between the scapula and the
thoracic wall; they consist of fragmented and enlarged
elastic fibres embedded in collagenous matrix that often
occur bilaterally [1-4]. They are commonly found in active
subjects beyond their 50th year [1-4], but may also affect
children [5]. In elderly patients, this tumor was inciden-
tally found in up to 2% by CT imaging [6]. Autopsy stud-
ies reported an even higher incidence of 13% to 17%,
revealing pre-elastofibroma-like morphologic changes
even in 81% of the autopsies [7,8]. In subjects over 55
years of age, prevalence is given with up to 24% [8]. In the
differential diagnosis of soft tissue tumors located at the
thoracic wall, one should be aware of this surprisingly
common lesion. We followed up a series of seven cases
with reference to clinical findings, further clinical course
and functional result after resection, as well as recurrence.
Patients and methods
Data for this case series were acquired retrospectively from
the patients' charts, physical examination and phone calls
to their general practicioners. From 1996 to 2005, seven
patients with diagnosis elastofibroma dorsi were treated
at our institutions (two center study).
All patients underwent MRI imaging preoperatively. Three
patients were core biopsied in advance; for two patients,
the diagnosis was made by instantaneous section. Two
patients were primarily resected completely without pre-
or intraoperative histopathologic verification of the diag-
nosis. In all patients, marginal complete resection was
performed and tissue specimens were sent in for patho-
logical evaluation to an experienced soft tissue patholo-
gist. Defects were closed primarily.
Results
Five patients were female; two were male. The average age
at the time of the treatment was 63.7 years and ranged
from 46 to 79 years. Follow-up data was available for all
patients. Follow-up time ranged from four months to nine
years and averaged 53 months.
The tumors were attached to the thoracic wall, located
between the serratus anterior muscle and the chest wall in
their anterior and between serratus and latissimus dorsi
muscle in their posterior extension (figure 1). In four
cases, the tumor was located at the right side; in two cases,
at the left side; and, in one patient, it was growing bilater-
ally. In only three cases, the lesion was located at the side
of the dominant hand. None of the patients was exten-
sively active during their lifetime. In most of the patients,
the predominant symptoms were swelling and snapping
of the scapula. The tumor sizes ranged from 3 to 13 cm.
On MRI in all patients the margins of the elastofibromas
were well defined. The tumors were located inferior to the
margo inferior of the scapula, adjacent to the thorcic wall.
The central parts contained fibrous masses with low signal
intensity on T1- and T2-weighted images. Hyperintens sig-
nals in T1- and T2- weighted images represented intermin-
gled fatty tissue. On STIR-sequences the fatty tissue also
showed low signal intensity, with a slightly higher inten-
sity of the the fibrous tissue. Focal aereas of high signal
intensity STIR-sequences may also be interpreted as
edema within the lesion. In figure 2 the typical aspect of a
bilateral elastofibroma on MRI is shown (figure 2).
Photographs of the tumour aspect of patients 1 (a) and 1 (b) Figure 1
Photographs of the tumour aspect of patients 1 (a) and 1 (b).World Journal of Surgical Oncology 2007, 5:15 http://www.wjso.com/content/5/1/15
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In one patient, dyspnea and hypertension occurred coin-
cidentally with the elastofibroma and disappeared with
tumor resection. Due to the mild disturbances caused by
the lesions, the patients sought medical advice only late
after the onset of the symptoms (4 months to 4 years). In
all patients but one, postoperative seroma (which had to
be punctuated) occurred; however, at follow-up time, no
patient reported any decrease of function or sensation at
the shoulder or the arm of the operated side. No relapse
of the tumor occurred. One patient could not be followed
up personally as the patient died of cerebral apoplexy 13
months after treatment. At that time, however, the patient
had neither recurrence of the elastofibroma nor any dis-
turbances caused by the tumor resection. A detailed sum-
mary of the patients' data is given in table 1.
Pathology
Macroscopic findings: The soft tissue lesions were typi-
cally characterized by an irregular, poorly defined fibroe-
lastotic mass with a slightly rubbery, elastic consistence.
The cut surface showed strands of white and yellow tissue
caused by the entrapment of fatty remnants, similar to a
"checkerboard" pattern (figure 3). The tumours were not
encapsulated. Microscopic findings: Histologically, all
tumors were composed of fibrous, collagenous strands
and plump, sometimes elongated mostly round-shaped
MRI of bilateral elastofibroma with the tumour being located between the thoracic wall, the anterior serratus, and the latis- simus dorsi muscle (coronal (2a) and axial (2c) T1-weighted images): The small arrows indicate the medial margins of the  lesions containing fatty (bright) and fibrous (dark) tissue Figure 2
MRI of bilateral elastofibroma with the tumour being located between the thoracic wall, the anterior serratus, and the latis-
simus dorsi muscle (coronal (2a) and axial (2c) T1-weighted images): The small arrows indicate the medial margins of the 
lesions containing fatty (bright) and fibrous (dark) tissue. The tumours are located between the thoracic wall, the anterior ser-
ratus, and the latissimus dorsi muscle. The large arrows points to the margo inferior of the scapula. Figures [2b] and [2d] show 
the corresponding STIR -sequences with a slightly inhomogenous signal intensity within the elastofibromas.W
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Table 1: Detailed summary of patient data
Patient Age Gender Profession Handedness Location Tumor 
extension 
in cm
Symptom Comorbidity Duration of 
symptoms before 
treatment
Operative 
procedure
Recurrence Complic
ation
Disturbances 
at follow up
1 68 F housewife right right subscapular region 
between serratus and latissimus 
muscle
6x6x4 swelling hypertension 4 years complete 
marginal 
resection
no seroma none
2 76 F housewife right right subscapular region 
between serratus and latissimus 
muscle
12x7x5 pain coronary artery 
disease, diabetes 
mellitus IIb
9 months complete 
marginal 
resection
no seroma none, died of 
cerebral 
apoplexy 13 
months after 
treatment
3 46 F nurse right left subscapular region between 
serratus and latissimus muscle
5.5x5x2 swelling hypertension, 
hyperthyreosis
4 months complete 
marginal 
resection
no seroma none
4 71 F housewife left right subscapular region 
between serratus and latissimus 
muscle
3x3x3 swelling Leiomyosarcoma both 
lower leg,s 
gonarthrosis
2 years complete 
marginal 
resection
no none none
5 47 M engineer right left subscapular region betweeen 
latissismus and serratus muscle
5x4x2 pain hypertension 4 years complete 
marginal 
resection
no hematom
a
none
right subscapular region 
between latissimus, serratus, and 
rhomboideus maj. muscle
13x11x3 pain 4 years complete 
marginal 
resection
no seroma none
6 59 M engineer right right subscapular region, 
between latissismus and serratus 
muscle
9x7x2.5 pain none 1.5 years complete 
marginal 
resection
no hematom
a, seroma
none
7 79 F housewife right left subscapular region, between 
latissismus and serratus muscle
6.5x2.5x5 swelling dyspnea 
hypertension
arteriosclerosis 1 year complete 
marginal 
resection
no seroma none, complete 
remission of 
dyspnea and 
hypertensionWorld Journal of Surgical Oncology 2007, 5:15 http://www.wjso.com/content/5/1/15
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elastic fibres which were densely packed. The elastic struc-
tures typically formed discs or globules and sometimes
appeared in an "asbestos-body-like" fashion. These fibres
were difficult to detect using hematoxylin-eosine-staining,
especially during the frozen section procedure. They were
best highlighted using elastic stain (Elastica-van-Gieson)
which stained the fibres dark brown to black. The lesions
were predominantly hypocellular with fibrocytic and
fibroblastic cells without atypia and mitotic activity (fig-
ure 4a–c).
Discussion
The pathogenesis of elastofibroma dorsi is still unclear,
but repetitive microtrauma caused by friction between the
scapula and the thoracic wall may cause reactive hyper-
proliferation of fibroelastic tissue [9-13]. A systematic
review of the literature gave no further hints to the role of
microtraumatization because most authors did not pro-
vide any information about their patients' activity. There
is a striking predominance of the female gender from 5:4
to 13:1, depending on the study, suggesting that micro-
trauma alone cannot be the major factor in genesis of this
lesion [1-4]. Previous publications referred to other sites
of friction exposure as the tricuspid valve, axilla, foot, and
ischial tuberosity; however, other reports of less common
sites of manifestation with lower mechanical stress like
the mediastinum, the stomach, the greater omentum, the
inguinal region, the orbita, and the intraspinal space sup-
port this theory [3,11,14-18]. With the tumors occurring
at the dominant and nondominant hand site in our
patients, there seemed to be no association to mechanic
stress assuming the dominant side was exposed to a
higher level of repetitive microtrauma during lifetime.
Additionally, only one of our patients had a history of
extensive physical activity in his life (canoeist). Several
authors proposed vascular insufficiency as a possible rea-
son for the degenerative changes [8,12]. A familial predis-
position with an underlying enzymatic defect may exist in
30%, but this has never been finally proved [2,19,20].
Large case series from Japan strongly suggest that heredi-
tary factors may be a predisposition for this lesion [2,21].
The nature of the altered elastic fibres is disputed and con-
troversial. They may be caused by abnormal elastogenesis
or by degenerating as a secondary process, or even by a
combination of both processes [8,13,20,22,23].
The symptoms of elastofibroma dorsi depend on the site
and size of the lesion and may present as shoulder pain or
Macroscopic aspect of elastofibroma dorsi: Poorly defined fibroelastotic tumor with entrapment of fatty remnants Figure 3
Macroscopic aspect of elastofibroma dorsi: Poorly defined fibroelastotic tumor with entrapment of fatty remnants.World Journal of Surgical Oncology 2007, 5:15 http://www.wjso.com/content/5/1/15
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snapping scapula as in our patients. In 50% of the cases,
the tumor remains asymptomatic or causes mild discom-
fort only, explaining the long periods of up to 67 years
between the onset of the symptoms and treatment [1-
4,24,25]. Large lesions may simulate scapula alata, by ele-
vating the scapula. If palpable, the tumor may mimic sem-
imobility due to its elastic fibres, but intraoperatively it
normally shows adherent to the surrounding tissue. It
occurs predominantly at the right side but, in up to 50%
of the cases, it is found bilaterally [8]. In our collective,
this proportion was 14%. The coincidence of hyperten-
sion and dyspnea with elastofibroma has not yet been
described and may be unrelated, whereas a large tumor
may disturb thoracic elasticity and movements and there-
fore could cause dyspnea by interfering with the breathing
motor function.
Aside from a possible soft tissue signal intensity or ele-
vated scapula, plain radiographs do not show specific
changes. On MRI, probably the most reliable non-inva-
sive technique in diagnosis, the lesions mostly show a sig-
nal intensity, comparable to that of muscle, margins are
well defined and signal intensity is mostly low. Inter-
spersed adipose strands cause a heterogeneous structure
with longitudinal areas of higher signal intensity [4,11,26-
29]. In all of our patients the findings on MRI were con-
sistent with the criteria mentioned above. After applica-
tion of contrast agent, normally faint but also marked
enhancement mimicking malignancy may be observed
[30-32]. CT shows the same changes but is less sensitive
for visualizing the strands of fatty tissue [29]. On PET-CT
radiotracer accumulation of the hypermetabolic tumor
has been described [33]. Differential diagnosis includes
sarcomas, aggressive fibromatosis, lipoma, and fibroma.
Ultrasound patterns of the tumor are characteristic includ-
ing fasciculated structures with hypo- and hyperechogene-
ous striae of different thickness similar to that of muscle
tissue but less organized. Colour Doppler shows vascular-
ization patterns similar to the surrounding muscle. In the
hands of an experienced examiner, ultrasound may repre-
sent a quick and cheap diagnostic tool [34-36]. Due to its
muscle like appearance in all of the imaging procedures
mentioned, the lesion may go undiagnosed or, in case of
abnormal features, misdiagnosed. The advanced age of
the patients, the typical localization, female gender or
bilateral manifestation support the presumptive diagnosis
of elastofibroma. In these cases and with clear imaging
findings, one may refrain from biopsy. In all other cases,
Microscopic findings in elastofibroma dorsi: 4a): Fibrous, collagenous strands intermingled with fat cells (hematoxylin-eosine- staining) Figure 4
Microscopic findings in elastofibroma dorsi: 4a): Fibrous, collagenous strands intermingled with fat cells (hematoxylin-eosine-
staining). 4b): Collagenous material and roundly shaped elastic fibres, mesenchymal cells with bland nuclei (hematoxylin-eosine-
staining). 4c): Elastic fibres and structures forming discs and globules stained dark brown to black using an elastic stain (Elastica-
van-Gieson).World Journal of Surgical Oncology 2007, 5:15 http://www.wjso.com/content/5/1/15
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in contrast to other authors [26,28,37-40], we strongly
recommend that tumor material be obtained to confirm
the presumptive or to establish another diagnosis,
because MRI, CT or ultrasound and clinical findings can-
not give final safety [1,2,32,41-45]. Fine needle aspiration
[46] is not recommended because of the inherent
hypocellularity of the tumor. An open biopsy or at least a
core needle biopsy should be performed to get a repre-
sentative tissue specimen. Histomorphologically, the
diagnosis is based on the presence of the altered elastic
fibres embedded in a collagenous matrix, riddled with
various amounts of fat cells. These elastic fibres are often
fragmented into discs or globules and larger than regular
ones [13,20,47]. Ultrastructurally, the elastinophilic
material frequently contains a central core of mature elas-
tic tissue and appears to be secreted by active fibroblasts;
this further substantiates the thesis that the elastic mate-
rial in elastofibroma is derived from excessive production
by fibroblasts rather than from elastotic degeneration of
collagen. Dense granular bodies within the fibroblast
cytoplasm are described, which are thought to represent
elastin or elastin precursors [48].
In incidental diagnosis of asymptomatic lesions there is
no need for excision as malignant transformation has
never been described. Only in cases of discomfort, snap-
ping or blocking scapula and pain, marginal resection is
widely recommended according to the psychological and
physical strain of the patient [1,2,49], but anecdotal
reports mentioned good results with radiotherapy as well
[16,17]. This may be an option especially for manifesta-
tions in unresectable locations. The high incidence of
seromas in our patients, whereas there is no report about
seromas in the literature, may be a result of insufficient
immobilisation. Taking into account the usually
advanced age of the patients, immobilisation bears the
risk of remaining stiffness in the shoulder girdle, whereas
punctuation of a seroma may only prolong reconvales-
cence and cause mild discomfort. Our patients retrospec-
tively did not experience postoperative seroma as relevant
discomfort. All patients were free of the disease at follow-
up time, concurring with the literature reporting only a
few cases of recurrence [2,32,50].
Conclusion
In differential diagnosis of soft tissue tumors located at
the infrascapular region, elastofibroma should be consid-
ered as likely diagnosis by the surgeon and the surgical
pathologist. We prefer MRI to localize and identify the
lesion. In elderly patients or patients with bilateral mani-
festation and definite findings in imaging, it may be justi-
fied to refrain from biopsy. Otherwise, open biopsy
should be performed to exclude malignancy and to reas-
sure the asymptomatic patient that no surgical treatment
is necessary. Unnecessary wide and radical resections in
the symptomatic patient can be avoided because marginal
resection has proven to be sufficient. We recommend
postoperative wound drainage and compression garment,
as well as shoulder immobilization for one week to reduce
postoperative seroma.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
AD conceptualised the study, gathered the data and wrote
the manuscript.
PV analysed and interpreted the data.
KB acquired and weighed the data.
WP evaluated the MRI findings and edited the radiology
section.
DW was involved in drafting the manuscript and critically
revising it.
ML interpreted the data and revised the manuscript.
LS reviewed the literature and analysed the data.
HS initiated the study and supervised the process. He gave
final approval for publication.
CK performed the histopathological evaluation and inter-
pretation of the data.
Acknowledgements
We thank Amanda Daigeler for her formal English revision of the manu-
script
References
1. Briccoli A, Casadei R, Di Renzo M, Favale L, Bacchini P, Bertoni F:
Elastofibroma dorsi.  Surg Today 2000, 30(2):147-152.
2. Nagamine N, Nohara Y, Ito E: Elastofibroma in Okinawa. A clin-
icopathologic study of 170 cases.  Cancer 1982, 50(9):1794-1805.
3. Naylor MF, Nascimento AG, Sherrick AD, McLeod RA: Elastofi-
broma dorsi: radiologic findings in 12 patients.  AJR Am J Roent-
genol 1996, 167(3):683-687.
4. Oueslati S, Douira-Khomsi W, Bouaziz MC, Zaouia K: Elastofi-
broma dorsi: A report on 6 cases.  Acta Orthop Belg 2006,
72(2):237-242.
5. Marin ML, Perzin KH, Markowitz AM: Elastofibroma dorsi: benign
chest wall tumor.  J Thorac Cardiovasc Surg 1989, 98(2):234-238.
6. Brandser EA, Goree JC, El-Khoury GY: Elastofibroma dorsi: prev-
alence in an elderly patient population as revealed by CT.  AJR
Am J Roentgenol 1998, 171(4):977-980.
7. Giebel GD, Bierhoff E, Vogel J: Elastofibroma and pre-elastofi-
broma--a biopsy and autopsy study.  Eur J Surg Oncol 1996,
22(1):93-96.
8. Jarvi OH, Lansimies PH: Subclinical elastofibromas in the scapu-
lar region in an autopsy series.  Acta Pathol Microbiol Scand [A]
1975, 83(1):87-108.
9. Jarvi O, Saxen E: Elastofibroma dorsi.  Acta Pathol Microbiol Scand
1961, 51(Suppl 144):83-84.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
World Journal of Surgical Oncology 2007, 5:15 http://www.wjso.com/content/5/1/15
Page 8 of 8
(page number not for citation purposes)
10. Machens HG, Mechtersheimer R, Gohring U, Schlag PN: Bilateral
elastofibroma dorsi.  Ann Thorac Surg 1992, 54(4):774-776.
11. Hoffman JK, Klein MH, McInerney VK: Bilateral elastofibroma: a
case report and review of the literature.  Clin Orthop Relat Res
1996:245-250.
12. Stemmermann GN, Stout AP: Elastofibroma dorsi.  Am J Clin Pathol
1962, 37:499-506.
13. Winkelmann RK, Sams WM Jr.: Elastofibroma. Report of a case
with special histochemical and electron-microscopic studies.
Cancer 1969, 23(2):406-415.
14. De Nictolis M, Goteri G, Campanati G, Prat J: Elastofibrolipoma of
the mediastinum. A previously undescribed benign tumor
containing abnormal elastic fibers.  Am J Surg Pathol 1995,
19(3):364-367.
15. Renshaw TS, Simon MA: Elastofibroma.  J Bone Joint Surg Am 1973,
55(2):409-412.
16. Prete PE, Henbest M, Michalski JP, Porter RW: Intraspinal elastofi-
broma. A case report.  Spine 1983, 8(7):800-802.
17. Deutsch GP: Elastofibroma dorsalis treated by radiotherapy.
Br J Radiol 1974, 47(561):621-623.
18. Mohan JC, Goel PK, Gambhir DS, Khanna SK, Arora R: Calcified
mobile papillary fibroelastoma of the tricuspid valve: a case
report.  Indian Heart J 1987, 39(3):237-239.
19. Enjoji M, Sumiyoshi K, Sueyoshi K: Elastofibromatous lesion of
the stomach in a patient with elastofibroma dorsi.  Am J Surg
Pathol 1985, 9(3):233-237.
20. Fukuda Y, Miyake H, Masuda Y, Masugi Y: Histogenesis of unique
elastinophilic fibers of elastofibroma: ultrastructural and
immunohistochemical studies.  Hum Pathol 1987, 18(5):424-429.
21. Sakae K: Elastofibroma dorsi: Clinicopathological and elec-
tron microscope studies.  Acta Med Univ Kagoshimaensis 1973,
25(3):1-29.
22. Akhtar M, Miller RM: Ultrastructure of elastofibroma.  Cancer
1977, 40(2):728-735.
23. Jarvi OH, Saxen AE, Hopsu-Havu VK, Wartiovaara JJ, Vaissalo VT:
Elastofibroma--a degenerative pseudotumor.  Cancer 1969,
23(1):42-63.
24. Majo J, Gracia I, Doncel A, Valera M, Nunez A, Guix M: Elastofi-
broma dorsi as a cause of shoulder pain or snapping scapula.
Clin Orthop Relat Res 2001:200-204.
25. Greenberg JA, Lockwood RC: Elastofibroma dorsi. A case
report and review of the literature.  Orthop Rev 1989,
18(3):329-333.
26. Yu JS, Weis LD, Vaughan LM, Resnick D: MRI of elastofibroma
dorsi.  J Comput Assist Tomogr 1995, 19(4):601-603.
27. Soler R, Requejo I, Pombo F, Saez A: Elastofibroma dorsi: MR and
CT findings.  Eur J Radiol 1998, 27(3):264-267.
28. Massengill AD, Sundaram M, Kathol MH, el-Khoury GY, Buckwalter
JH, Wade TP: Elastofibroma dorsi: a radiological diagnosis.
Skeletal Radiol 1993, 22(2):121-123.
29. Malghem J, Baudrez V, Lecouvet F, Lebon C, Maldague B, Vande Berg
B: Imaging study findings in elastofibroma dorsi.  Joint Bone
Spine 2004, 71(6):536-541.
30. Schick S, Zembsch A, Gahleitner A, Wanderbaldinger P, Amann G,
Breitenseher M, Trattnig S: Atypical appearance of elastofi-
broma dorsi on MRI: case reports and review of the litera-
ture.  J Comput Assist Tomogr 2000, 24(2):288-292.
31. Zembsch A, Schick S, Trattnig S, Walter J, Amann G, Ritschl P:
Elastofibroma dorsi. Study of two cases and magnetic reso-
nance imaging findings.  Clin Orthop Relat Res 1999:213-219.
32. Kransdorf MJ, Meis JM, Montgomery E: Elastofibroma: MR and CT
appearance with radiologic-pathologic correlation.  AJR Am J
Roentgenol 1992, 159(3):575-579.
33. Pierce JC 3rd, Henderson R: Hypermetabolism of elastofibroma
dorsi on PET-CT.  AJR Am J Roentgenol 2004, 183(1):35-37.
34. Cota C, Solivetti F, Kovacs D, Cristiani R, Amantea A: Elastofi-
broma dorsi: histologic and echographic considerations.  Int J
Dermatol 2006, 45(9):1100-1103.
35. Bianchi S, Martinoli C, Abdelwahab IF, Gandolfo N, Derchi LE, Dam-
iani S: Elastofibroma dorsi: sonographic findings.  AJR Am J
Roentgenol 1997, 169(4):1113-1115.
36. Solivetti FM, Bacaro D, Di Luca Sidozzi A, Cecconi P: Elastofibroma
dorsi: ultrasound pattern in three patients.  J Exp Clin Cancer Res
2003, 22(4):565-569.
37. Baudrez V, Malghem J, Van de Berg B, Lebon C, Lecouvet F, Maldague
B: [Ultrasonography of dorsal elastofibroma. Apropos of 6
cases].  J Radiol 1998, 79(6):549-551.
38. Gould ES, Javors BR, Morrison J, Potter H: MR appearance of bilat-
eral periscapular elastofibromas.  J Comput Assist Tomogr 1989,
13(4):701-703.
39. Kudo S: Elastofibroma dorsi: CT and MR imaging findings.
Semin Musculoskelet Radiol 2001, 5(2):103-105.
40. Nishida A, Uetani M, Okimoto T, Hayashi K, Hirano T: Bilateral
elastofibroma of the thighs with concomitant subscapular
lesions.  Skeletal Radiol 2003, 32(2):116-118.
41. Pisharodi LR, Cary D, Bernacki EG Jr.: Elastofibroma dorsi: diag-
nostic problems and pitfalls.  Diagn Cytopathol 1994,
10(3):242-244.
42. Berthoty DP, Shulman HS, Miller HA: Elastofibroma: chest wall
pseudotumor.  Radiology 1986, 160(2):341-342.
43. Ghiatas AA, Armstrong S, Tio FO: Case report 583: Elastofi-
broma dorsi.  Skeletal Radiol 1989, 18(8):619-622.
44. Lang P, Suh KJ, Grampp S, Steinbach L, Steiner E, Peterfy C, Tirman P,
Schwickert H, Rosenau W, Genant HK: [CT and MRI in elastofi-
broma. A rare, benign soft tissue tumor].  Radiologe 1995,
35(9):611-615.
45. Liessi G, Tregnaghi A, Barbazza R, Scapinello A, Muzzio PC: Elastofi-
broma: CT and MR findings.  J Belge Radiol 1991, 74(1):37-39.
46. Domanski HA, Carlen B, Sloth M, Rydholm A: Elastofibroma dorsi
has distinct cytomorphologic features, making diagnostic
surgical biopsy unnecessary: cytomorphologic study with
clinical, radiologic, and electron microscopic correlations.
Diagn Cytopathol 2003, 29(6):327-333.
47. Nakamura Y, Ohta Y, Itoh S, Haratake A, Nakano Y, Umeda A, Shima
H, Tomoda N: Elastofibroma dorsi. Cytologic, histologic,
immunohistochemical and ultrastructural studies.  Acta Cytol
1992, 36(4):559-562.
48. Dixon AY, Lee SH: An ultrastructural study of elastofibromas.
Hum Pathol 1980, 11(3):257-262.
49. Schafmayer C, Kahlke V, Leuschner I, Pai M, Tepel J: Elastofibroma
dorsi as differential diagnosis in tumors of the thoracic wall.
Ann Thorac Surg 2006, 82(4):1501-1504.
50. McGregor JC, Rao SS: Elastofibroma: a rare cause of painful
shoulder.  Br J Surg 1974, 61(7):583-584.